Drug Information

Drug General Information
Drug ID
D0ZY7X
Former ID
DNC010259
Drug Name
GNF-PF-2094
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530517]
Structure
Download
2D MOL

3D MOL
Formula
C18H24N4
Canonical SMILES
CC1=CC(=NC(=N1)NCC2=CC=CC=C2)NC3CCCCC3
InChI
1S/C18H24N4/c1-14-12-17(21-16-10-6-3-7-11-16)22-18(20-14)19-13-15-8-4-2-5-9-15/h2,4-5,8-9,12,16H,3,6-7,10-11,13H2,1H3,(H2,19,20,21,22)
InChIKey
GDKCAAWSNQLXNX-UHFFFAOYSA-N
PubChem Compound ID
697226
Target and Pathway
Target(s) Cytochrome P450 2D6 Target Info Inhibitor [530517]
KEGG Pathway Metabolism of xenobiotics by cytochrome P450
Drug metabolism - cytochrome P450
Serotonergic synapse
Reactome Xenobiotics
WikiPathways Metapathway biotransformation
Tamoxifen metabolism
Oxidation by Cytochrome P450
Vitamin D Receptor Pathway
Aripiprazole Metabolic Pathway
Fatty Acid Omega Oxidation
Codeine and Morphine Metabolism
References
Ref 530517Bioorg Med Chem Lett. 2010 Jan 1;20(1):228-31. Epub 2009 Oct 31.Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines.
Ref 530517Bioorg Med Chem Lett. 2010 Jan 1;20(1):228-31. Epub 2009 Oct 31.Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.